ARCHIVES

Blincyto Demonstrates Response In Minimal Residual Disease ALL

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Jane Henney, Former NCI Deputy Director, Named FDA Deputy Commissioner For Operations

November 15, 1991

DRCCA Completes New Cancer control Research Guidelines

August 5, 1983

Researchers Link Cancer Risk And DMPA Birth Control Use

April 27, 2012

Gallo, Four Others Share Lasker Award

November 19, 1982

In Brief: Patterns Of care Study Leads “Part Tie” Radiotherapists To Drop Out, Sheline Says

July 22, 1977

NCI To Spend About $150 Mil. On Cancers That Affect Only Women

April 26, 1991